CGON Insider Buying
The table below summarizes the most recent CGON insider buying information — the latest buy being $24,814,453.95 by Brian Guan-chyun Liu on 6/25/2026, with links to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall Street, there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why CGON insider buys like these are important for investors to follow.
| Date | Insider | Price | Amount |
|---|---|---|---|
| 6-25-2026 Insider Buy |
Brian Guan-chyun Liu |
$66.87 CAGR » |
$24,814,453.95 371,085 shares |
| 9-11-2025 Insider Buy |
Brian Guan-chyun Liu |
$33.00 CAGR » |
$49,999,983.00 1,515,151 shares |
| 1-29-2024 Insider Buy |
Decheng Capital Global Life Sciences Fund IV, L.P. |
$19.00 CAGR » |
$7,600,000.00 400,000 shares |
Also See: SEC filings
CG Oncology Insider Purchase CAGR Analysis
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 06/26/2026 | |
| End date: | 07/10/2026 | |
| Start price/share: | $71.96 | |
| End price/share: | $75.24 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 4.56% | |
| Annualized Gain: | 118.84% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $10,456.00 | |
| Years: | 0.04 | |
